Eledon Pharmaceuticals, Inc. (ELDN)

NASDAQ: ELDN · Real-Time Price · USD

3.400

-0.170 (-4.76%)

At close: Jul 28, 2026, 4:00 PM EDT

3.460

+0.060 (1.76%)

After-hours: Jul 28, 2026, 5:15 PM EDT

Eledon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.15	22.81	20.55	4.61	56.41	84.83
Short-Term Investments	104.94	110.53	119.63	46.49	-	-
Cash & Short-Term Investments	111.09	133.34	140.18	51.1	56.41	84.83
Cash Growth	-11.04%	-4.88%	174.31%	-9.41%	-33.51%	-25.71%
Other Current Assets	2.49	2.35	3.55	5.03	3.11	3.51
Total Current Assets	113.57	135.69	143.73	56.13	59.52	88.35
Net Property, Plant & Equipment	0.53	0.61	0.93	0.37	0.74	0.77
Other Intangible Assets	32.39	32.39	32.39	32.39	32.39	32.39
Goodwill	-	-	-	-	-	48.65
Other Long-Term Assets	0.18	0.32	0.36	0.19	0.15	0.4
Total Assets	146.67	169.01	177.41	89.07	92.79	170.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.59	3.63	5.83	0.97	2.2	1.81
Current Portion of Leases	0.37	0.36	0.31	0.38	0.36	0.37
Other Current Liabilities	6.5	14.36	5.43	2.55	3.91	2.22
Total Current Liabilities	13.46	18.34	11.58	3.9	6.48	4.4
Long-Term Leases	0.19	0.28	0.64	-	0.38	0.4
Other Long-Term Liabilities	32.57	13.6	47.05	77.96	1.75	1.75
Total Long-Term Liabilities	32.75	13.89	47.69	77.96	2.14	2.15
Total Liabilities	46.21	32.23	59.27	81.86	8.61	6.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.08	0.08	0.06	0.02	0.01	0.01
Additional Paid-in Capital	484.99	482.19	417.95	270.89	-	278.88
Accumulated Other Comprehensive Income	-0.07	0.02	0.03	-	-	-
Retained Earnings	-440.23	-401.2	-355.59	-319.4	-202.87	-114.9
Total Common Shareholders' Equity	44.76	81.09	62.45	-48.49	-202.85	164
Minority Interest	55.69	55.69	55.69	55.69	-	-
Shareholders' Equity	100.46	136.78	118.14	7.21	-202.85	164
Total Liabilities & Equity	146.67	169.01	177.41	89.07	92.79	170.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.56	0.64	0.95	0.38	0.75	0.77
Net Cash (Debt)	110.53	132.7	139.22	50.72	55.66	84.06
Net Cash Growth	-10.86%	-4.69%	174.50%	-8.88%	-33.78%	-26.29%
Net Cash Per Share	1.22	1.62	2.87	2.06	3.90	5.67
Book Value	44.76	81.09	62.45	-48.49	-202.85	164
Book Value Per Share	0.49	0.99	1.29	-1.97	-14.20	11.07
Tangible Book Value	12.38	48.7	30.06	-80.87	-235.24	82.96
Tangible Book Value Per Share	0.14	0.60	0.62	-3.28	-16.47	5.60

SEC Filings: 10-K · 10-Q